TGen-led study of metastatic melanoma secures $2 million grant

(The Translational Genomics Research Institute) Like a medical marathon, physicians run to keep up with metastatic cancer as it races ahead, outsmarting one treatment after another, and this is especially true for patients with metastatic melanoma. Now, some of the nation's top biomedical institutes -- led by the Translational Genomics Research Institute, an affiliate of City of Hope -- have received a $2 million federal grant towards discovering a new way to detect and track metastatic melanoma and understand how it escapes treatment.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news